Clinical Trial Update: Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research [Phase 4]

View source ↗

Summary

A Phase 4 multicenter clinical trial update evaluating Endostar for advanced non-small cell lung cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: Nanjing NingQi Medicine Science and Technology Co., Ltd. | Conditions: Non-small Cell Lung Cancer | Phase 4 | Status: UNKNOWN